RE:RE:RE:RE:RE:It' could be that they are waiting for---Eoganacht ... I agree.
I'm pretty sure that TLT management will indeed produce a clearer picture @270 days, considering this recent statement:
As of May 30: The maintenance study treatment (so, the 2nd dose) has been provided to 15 patients, with 11 maintenance study treatments pending That should then set the tone for them to start promoting the technology to analysts and start getting coverages.
We will have data to compare against competition on a more solid ground. The underdosing of the first 12 patients prevented them to be proactive. Now, with 11 pending results for the 270-day period, this could be more significant on the CR %.
Interesting time ahead, no doubt.
_____________________________
Eoganacht - (6/23/2022 6:48:04 PM)
RE:RE:RE:RE:It' could be that they are waiting for---
We should have had 180 day results for the first 25 in March, 270 day results this month and 360 day results in September. It would be great if they let us know the 270 day CR rates of the first 25, which they should already have or will have shortly.